News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current ALDX market cap is 234.41M. The company's latest EPS is USD -0.6374 and P/E is -6.24.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.78M | -13.7M | -16.8M | -10.34M | -9.55M |
| Net Income | -14.55M | -12.9M | -15.62M | -8.99M | -8.19M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -63.07M | -36.42M | -56.22M | -62.68M | -42.8M |
| Net Income | -60.83M | -37.55M | -57.78M | -62.03M | -37.54M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 189.69M | 181.29M | 168.22M | 155.62M | 147.28M |
| Total Liabilities | 27.5M | 30.28M | 30.98M | 25.73M | 24.27M |
| Total Equity | 162.19M | 151.01M | 137.24M | 129.88M | 123.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 75.52M | 83.35M | 233.14M | 181.29M | 148.33M |
| Total Liabilities | 27.44M | 23.84M | 27.4M | 30.28M | 28.53M |
| Total Equity | 48.08M | 59.51M | 205.74M | 151.01M | 119.8M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -45.41M | -56.64M | -9.44M | -22.8M | -30.83M |
| Investing | -56.95M | -29.95M | 30M | 30M | 30M |
| Financing | 1.22M | 1.22M | 53k | 58k | -257k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -44.98M | -37.49M | -42.56M | -56.64M | -30.33M |
| Investing | 18.48M | 29.02M | -8k | -29.95M | 30M |
| Financing | 23.58M | 41.9M | 194.5M | 1.22M | -1.27M |
| Market Cap | 234.41M |
| Price to Earnings Ratio | -6.24 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.64 |
| Price to Book Ratio | 1.96 |
| Dividend Yield | - |
| Shares Outstanding | 58.9M |
| Average Volume (1 week) | 598.27k |
| Average Volume (1 Month) | 815.09k |
| 52 Week Change | -62.42% |
| 52 Week High | 11.97 |
| 52 Week Low | 1.42 |
| Spread (Intraday) | 0.2 (4.94%) |
| Company Name | Aldeyra Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.aldeyra.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
